Category Archives: Trademarks
Apple’s GC Retires
Bruce Sewell, Apple’s’s general counsel since 2009, announced his retirement Friday after eight years as captain of Apple’s legal and security affairs. …source…
Posted in Business of Trademarks, Miscellaneous
Leave a comment
“Naked” Licenses
Failure to exert quality control, or otherwise properly supervise the nature and quality of a licensee’s use of your trademarks, results in what’s known as a “naked license” that can strip your company (or client) of its trademark rights. Why … Continue reading
Posted in Post-Registration, Trademarks
Leave a comment
CSL Returns…for BMW
It appears that BMW has filed three applications filed by BMW for the trademark CSL in the United States. Filed on 19 April 2017, the marks are M2 CSL, M4 CSL, and M8 CSL. CSL is an acronym for Coupe Sport Leightbau, or … Continue reading
Posted in Trademarks, USPTO
Leave a comment
Be Vigilant!
Protecting a brand is not easy; it requires diligence and strategy. Unlike owners of other forms of intellectual property, trademark holders have an affirmative duty to police their trademarks, and can lose trademark rights if they fail to do so. … Continue reading
Posted in Practice Tips, Trademarks
Leave a comment
When Filing Maintenance Documents: Beware!
1613.17(a) Correcting Deficiencies in Affidavits or Declarations Timely Filed Within the Periods Set Forth in § 71(a) of the Act If the affidavit or declaration is filed during the periods set forth in § 71(a) of the Act (i.e., during … Continue reading
Posted in Post-Registration, Trademark Prosecution, USPTO
Leave a comment
USPTO Sued for Harassment
On January 6, 2016, Matthew Swyers, founder of The Trademark Company, filed a lawsuit against the U.S. Patent & Trademark Office claiming that the USPTO has violated his Constitutional rights in its investigation of his practices in the filing and prosecuting … Continue reading
Posted in Litigation, Trademark Prosecution, Trademarks
Leave a comment
Merck to Acquire IOMet Pharma
Merck has agreed to pay up to $400 million to acquire IOmet Pharma, a Scottish company that specializes in the development of small molecule-based cancer treatments. IOmet will operate as a division of Merck. The acquisition will include IOmet’s pre-clinical pipeline … Continue reading
Change in Trademark Law!
The Court of Appeals for the Federal Circuit has ruled that the name of an Asian-American band — The Slants — is private speech and therefore protected by the First Amendment. The government, the court writes, has no business trying … Continue reading
Posted in Litigation, Trademark Prosecution, Trademarks, Uncategorized
Tagged Trademark Litigation
Leave a comment
Bayer Loses CTM Opposition
On 29 October 2015, OHIM’s Opposition Division of the Office dismissed Bayer’s opposition against registration of the mark SALOSPIR & Design (No. 012351458). Bayer opposed Uni-Pharma SA’s application for the mark SALOSPIR & Design for pharmaceutical preparations in Class 5 based on three … Continue reading
Ipsen & Telesta Reach Deal
Ipsen and Telesta Therapeutics Inc. announced yesterday that they have entered into an exclusive licensing agreement for Ipsen to develop and commercialize MCNA1 for the treatment of high risk non-muscle invasive bladder cancer (NMIBC) in all countries of the world, … Continue reading
Darren Geliebter
Mathew Lombard
THE PRINCIPAL REGISTER 